Write in a clean editor, then format for Cephalalgia in one click — DocuGuru applies the official SAGE template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Cephalalgia is a peer-reviewed journal published by SAGE, covering Migraine and Headache Studies, Trigeminal Neuralgia and Treatments, Ophthalmology and Eye Disorders. Over its lifetime it has published 8,463 papers, which have received 295,259 citations.
| Publisher | SAGE |
|---|---|
| Reference style | Numbered (Vancouver) Numbered — [1], [2] in the text 1. Smith A, Jones B, Lee C. A representative article title. Cephalalgia. 2023;12(3):45–58.
Formats any DOI in Cephalalgia style. No sign-up. |
| Publishes research in | Migraine and Headache Studies Trigeminal Neuralgia and Treatments Ophthalmology and Eye Disorders Sympathectomy and Hyperhidrosis Treatments Neurological Complications and Syndromes |
| ISSN | 0333-1024 |
| Citation impact (2-yr) | 5.16 |
| h-index | 178 |
| i10-index | 4,614 |
| Top institutions publishing here | University of Copenhagen |
| Journal website | www.sagepub.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Free accessAbstractFirst published online January 25, 2018Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd editionAll Articleshttps://doi.org/10.1177/0333102417738202
An 8-month, double-blind, placebo-controlled, crossover trial of flunarizine in the prophylaxis of migraine has been performed in 70 children. After 4 weeks of medication-free base-line observation, 35 children (group A) received flunarizine (5 mg/day) and 35 (group B) received placebo over a 12-week period. After a 4-week washout they crossed treatments for another 12 weeks.…
This study, which is a part of the initiative 'Lifting The Burden: The Global Campaign to Reduce the Burden of Headache Worldwide', assesses and presents all existing evidence of the world prevalence and burden of headache disorders. Population-based studies applying International Headache Society criteria for migraine and tension-type headache, and also studies on headache in…
Cephalalgia has been successful by a number of measures in the last 12 months: our circulation is up particularly through electronic penetration in libraries, our submission rate has risen substantially and our impact factor remains high amongst clinical neuroscience journals. We are entering our fifth and last year of the current publisher’s contract. In the…
